牛牛AI助理已提取核心訊息
Michael F Dubin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], executed a transaction on January 29, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Michael F Dubin to the issuer was not specified, and there was no information provided regarding the number of shares held by Dubin after the transaction.
Michael F Dubin, a reporting person for Virpax Pharmaceuticals, Inc. [VRPX], executed a transaction on January 29, 2024. The details of the transaction, including the number of shares involved, the nature of the shares, the transaction price, and the total value of shares, were not disclosed in the announcement. The relationship of Michael F Dubin to the issuer was not specified, and there was no information provided regarding the number of shares held by Dubin after the transaction.
Virpax Pharmicals, Inc. [VRPX] 的舉報人邁克爾·杜賓於2024年1月29日執行了一項交易。公告中沒有披露交易的細節，包括所涉及的股票數量、股票的性質、交易價格和股票的總價值。沒有具體說明邁克爾·杜賓與發行人的關係，也沒有提供有關杜賓在交易後持有的股票數量的信息。
Virpax Pharmicals, Inc. [VRPX] 的舉報人邁克爾·杜賓於2024年1月29日執行了一項交易。公告中沒有披露交易的細節，包括所涉及的股票數量、股票的性質、交易價格和股票的總價值。沒有具體說明邁克爾·杜賓與發行人的關係，也沒有提供有關杜賓在交易後持有的股票數量的信息。
有用
沒用
